Framework Journal · one stock, one dated entry

Recorded 2025-12-31 · Permanent

Bristol Myers Squibb BMY

An entry written while the outcome is still unknown. It will be scored by what the market does next, and it will never be edited to look cleverer than it was.

The label
Markup

read at $57.27

Bristol Myers Squibb holds its Markup at $57.27.

PHINPOOPSC
  • PHPhase · the trend structure carries the Markup label
  • INInsiders · no filings inside 60 days, left as found
  • POPositioning · no disclosures inside 60 days, left as found
  • OPOptions · no verdict drawn today, left as found
  • SCScreen · does not pass the values gate

The investor read · the season, not the day

As held on the ledger · 2025-12-31
PhaseMarkup
Quantitative stateConsolidating, no directional conviction, held for 4 days
Price$57.27
Valuation15.70 trailing · 9.10 forward price to earnings
Values screenFAIL · score 10.0
Beta0.26

The trader read · the latest dated commentary

The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Entered 2026-07-03 · Markup

The dated journal · newest first, never edited

2026-07-03 Markup $57.27 +0.0% Entry 2

The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns.

2026-07-02 Markup $57.27 Entry 1

The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns.

Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.

The insider ledger · Form 4 filings, as filed

Most recent filings · BMY
DateInsiderTitleTypeSharesValue
2026-04-01 Elkins David V EVP, CFO Sale 30,000 $1,850,016
2025-09-02 Elkins David V EVP, CFO Sale 56,000 $2,650,480
2025-08-02 Short Bartie Wendy EVP, Corporate Affairs Sale 378 $16,719
2026-05-01 LENKOWSKY ADAM Officer 1,373 ·
2026-04-01 SHANAHAN KARIN Officer 3,307 ·
2026-04-01 ELKINS DAVID VINCENT Chief Financial Officer 30,000 $1,850,016
2026-03-10 PLENGE ROBERT M Officer 17,501 ·
2026-03-10 MEYERS GREGORY SCOTT Chief Technology Officer 25,892 ·
2026-03-10 SHANAHAN KARIN Officer 25,501 ·
2026-03-10 LENKOWSKY ADAM Officer 24,071 ·

Public filings, recorded as found. The full tape lives at Insider Intelligence.

The political ledger · congressional disclosures

Disclosures naming BMY
DatePoliticianPartyTypeAmount
7 May2026 Mike Kelly Republican sell 15K–50K

What holding actually paid · price plus dividends

If $1,000 had been placed · historical, not a promise
PeriodPrice thenPrice returnDivs per share$1,000 becameTotal return
1 month $55.67 +0.3% · $1,003 +0.3%
2 months $58.62 -4.7% · $953 -4.7%
3 months $58.35 -4.3% $0.63 $968 -3.2%
6 months $50.09 +11.5% $1.26 $1,140 +14.0%
1 year $47.59 +17.4% $2.50 $1,226 +22.6%
2 years $38.64 +44.6% $4.94 $1,573 +57.3%
3 years $56.40 -1.0% $7.28 $1,119 +11.9%
5 years $55.08 +1.4% $11.56 $1,224 +22.4%

Historical returns from market close data. Past performance does not guarantee future results.

This entry now belongs to the ledger. Whatever BMY does next, these words stay.

Bristol Myers Squibb · BMY · Markup · $57.27
Recorded 2025-12-31 · before the outcome · scored mechanically

Discover More
Alpha Insights Market Intelligence Titan Watch Ethical Screener Insider Intelligence Track Record Ethical Finance Zakat Calculator Iran Oil Tracker Foundry Indicators Options Calendar Composites Boycott Tracker Convergence Screener Fed Tracker Explore All Is It Halal? Earnings Calendar Dividend Screener Country Guides Glossary Join Free →

Get our weekly market brief free.